Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
XSO101
- Development stage
- Unknown
- Lead developer
- Xsome Biotech
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Inhalation
01
Overview
XSO101 is an inhalable exosome-based therapeutic developed by Xsome Biotech for the treatment of idiopathic pulmonary fibrosis (IPF) and usual interstitial pneumonia (UIP). It is the lead candidate of the NatEx™ (XO100-Series) platform, which utilizes naturally-derived exosomes and secretome harvested from lung spheroid cells (LSCs). These exosomes are designed to be delivered directly to the lungs via inhalation to modulate inflammatory and fibrotic pathways, potentially reversing or halting the progression of lung tissue scarring. The drug represents a biologic modality using extracellular vesicles as the therapeutic agent to deliver a complex mixture of bioactive molecules that target the underlying pathology of fibrotic lung diseases.
- Brand names
- NatEx
- Other names
- LSC exosomeslung spheroid cell-derived secretome/exosomeslung spheroid cell-derived exosomes
02
Targets
SARS-CoV-2 spike
Beyond the preview
Go deeper on XSO101.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on XSO101.